Vaccination and HIV-1 replication during highly active antiretroviral therapy.
Kroon
F P
FP
Beersma
M F
MF
Kroes
A C
AC
Groeneveld
P H
PH
van Dissel
J T
JT
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology* / Q000821:virology*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007252:Influenza Vaccines / Q000276:immunology*; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014611:Vaccination; D019562:Viral Load; D014779:Virus Replication
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D007252:Influenza Vaccines; D018894:Reverse Transcriptase Inhibitors